Clinical Trial Update: Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach [Phase 3]

View source ↗

Summary

Phase 3 trial studying EGCG supplementation as an anti-aggregation approach for progression rate in Multiple System Atrophy has completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• EGCG (epigallocatechin gallate)

Snippet

Sponsor: Dr. Johannes Levin | Conditions: Multiple System Atrophy | Phase 3 | Status: COMPLETED | Results posted: 2024-03-12